{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 3773, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de076-b0fc-7764-be49-9cb0f9de8ba9", "docSlug": "ed8052d583ef5c8745075e02dbad124b", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 31 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "traction", "function": "show_traction", "notes": "The slide presents two line charts showing tumor volume over time, illustrating the efficacy of THIO in primary treatment and rechallenge scenarios.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b0fc-7764-be49-9cb0f9de8ba9/21", "deckHref": "/decks/019de076-b0fc-7764-be49-9cb0f9de8ba9", "deckAnchorHref": "/decks/019de076-b0fc-7764-be49-9cb0f9de8ba9#slide-21", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b0fc-7764-be49-9cb0f9de8ba9", "docSlug": "ed8052d583ef5c8745075e02dbad124b", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 31 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide outlines a clinical trial process flow involving SCLC and NSCLC patient baskets, immune activation, and subsequent combination therapies leading to a Phase 3 expansion.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b0fc-7764-be49-9cb0f9de8ba9/22", "deckHref": "/decks/019de076-b0fc-7764-be49-9cb0f9de8ba9", "deckAnchorHref": "/decks/019de076-b0fc-7764-be49-9cb0f9de8ba9#slide-22", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b0fc-7764-be49-9cb0f9de8ba9", "docSlug": "ed8052d583ef5c8745075e02dbad124b", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 31 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b0fc-7764-be49-9cb0f9de8ba9/23", "deckHref": "/decks/019de076-b0fc-7764-be49-9cb0f9de8ba9", "deckAnchorHref": "/decks/019de076-b0fc-7764-be49-9cb0f9de8ba9#slide-23", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b0fc-7764-be49-9cb0f9de8ba9", "docSlug": "ed8052d583ef5c8745075e02dbad124b", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 31 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "unfair_advantage", "function": "present_solution", "notes": "The slide highlights both regulatory exclusivity (NCE) and a multi-layered patent strategy extending into the 2040s.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b0fc-7764-be49-9cb0f9de8ba9/24", "deckHref": "/decks/019de076-b0fc-7764-be49-9cb0f9de8ba9", "deckAnchorHref": "/decks/019de076-b0fc-7764-be49-9cb0f9de8ba9#slide-24", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b0fc-7764-be49-9cb0f9de8ba9", "docSlug": "ed8052d583ef5c8745075e02dbad124b", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 31 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "team_bio", "function": "other", "notes": "Includes headshots, professional summaries, and a grid of logos representing past company affiliations.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b0fc-7764-be49-9cb0f9de8ba9/25", "deckHref": "/decks/019de076-b0fc-7764-be49-9cb0f9de8ba9", "deckAnchorHref": "/decks/019de076-b0fc-7764-be49-9cb0f9de8ba9#slide-25", "loopMatches": [], "arcBeatMatches": [ { "to": 25, "from": 25, "beatId": "9fbd0f4f-19c1-44db-9443-532f590855fb", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Team", "beatSlug": "sequoia-pitch-team", "evidence": "The 'team_bio' slide presents the management team", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b0fc-7764-be49-9cb0f9de8ba9", "docSlug": "ed8052d583ef5c8745075e02dbad124b", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 31 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The slide contrasts the massive combined market of established CPIs ($42B) with the smaller market share of Libtayo ($0.5B) to frame the opportunity for partnership/growth.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b0fc-7764-be49-9cb0f9de8ba9/26", "deckHref": "/decks/019de076-b0fc-7764-be49-9cb0f9de8ba9", "deckAnchorHref": "/decks/019de076-b0fc-7764-be49-9cb0f9de8ba9#slide-26", "loopMatches": [], "arcBeatMatches": [ { "to": 26, "from": 26, "beatId": "6aa71901-b154-41b0-bf7f-47c4f9470244", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "The 'market_sizing' slide discusses market opportunity", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b0fc-7764-be49-9cb0f9de8ba9", "docSlug": "ed8052d583ef5c8745075e02dbad124b", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 31 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The slide uses market cap data to establish valuation benchmarks and cites recent M&A activity as a validation of the sector's value.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b0fc-7764-be49-9cb0f9de8ba9/27", "deckHref": "/decks/019de076-b0fc-7764-be49-9cb0f9de8ba9", "deckAnchorHref": "/decks/019de076-b0fc-7764-be49-9cb0f9de8ba9#slide-27", "loopMatches": [], "arcBeatMatches": [ { "to": 27, "from": 27, "beatId": "c7f2f0bf-1dc1-4fd5-a280-c10f80bfe30e", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Competition", "beatSlug": "sequoia-pitch-competition", "evidence": "The 'competitive_analysis' slide compares with other companies", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b0fc-7764-be49-9cb0f9de8ba9", "docSlug": "ed8052d583ef5c8745075e02dbad124b", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 31 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "timeline", "function": "plan_implementation", "notes": "The slide uses a grid-based timeline layout to map specific clinical events to calendar years.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b0fc-7764-be49-9cb0f9de8ba9/28", "deckHref": "/decks/019de076-b0fc-7764-be49-9cb0f9de8ba9", "deckAnchorHref": "/decks/019de076-b0fc-7764-be49-9cb0f9de8ba9#slide-28", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b0fc-7764-be49-9cb0f9de8ba9", "docSlug": "ed8052d583ef5c8745075e02dbad124b", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 31 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "appendix", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b0fc-7764-be49-9cb0f9de8ba9/29", "deckHref": "/decks/019de076-b0fc-7764-be49-9cb0f9de8ba9", "deckAnchorHref": "/decks/019de076-b0fc-7764-be49-9cb0f9de8ba9#slide-29", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b0fc-7764-be49-9cb0f9de8ba9", "docSlug": "ed8052d583ef5c8745075e02dbad124b", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 31 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 30, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes details on options, warrants, and insider ownership percentages.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b0fc-7764-be49-9cb0f9de8ba9/30", "deckHref": "/decks/019de076-b0fc-7764-be49-9cb0f9de8ba9", "deckAnchorHref": "/decks/019de076-b0fc-7764-be49-9cb0f9de8ba9#slide-30", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b0fc-7764-be49-9cb0f9de8ba9", "docSlug": "ed8052d583ef5c8745075e02dbad124b", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 31 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 31, "slideType": "product_demo", "function": "analyze_data", "notes": "The slide shows a biological mechanism of action (MOA) validation using TIFs as a biomarker.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b0fc-7764-be49-9cb0f9de8ba9/31", "deckHref": "/decks/019de076-b0fc-7764-be49-9cb0f9de8ba9", "deckAnchorHref": "/decks/019de076-b0fc-7764-be49-9cb0f9de8ba9#slide-31", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b194-750c-a1e9-eae1d42bc6f5", "docSlug": "9fdf48e9810bc95033985664c53d0e5a", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 24 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/MLhXKaLmFwHlSnbyTGckSRzW6Rr2JooNitqO1RsHk1o/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85ZmRmNDhlOTgxMGJjOTUwMzM5ODU2NjRjNTNkMGU1YS9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b194-750c-a1e9-eae1d42bc6f5/1", "deckHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5", "deckAnchorHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/ZZ9Tn8GUy2DRNmfgQjS9Spv2H5BtY5BtVhQK0HkDYio/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85ZmRmNDhlOTgxMGJjOTUwMzM5ODU2NjRjNTNkMGU1YS9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/3lJbosiOYD3jDz5JTE5cezMHXTTWTPi07k8ZuhS_uKs/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85ZmRmNDhlOTgxMGJjOTUwMzM5ODU2NjRjNTNkMGU1YS9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/l8lEaxylfzffiMRaBFhpeT6zsrGvgdueHDbprlNUXG8/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85ZmRmNDhlOTgxMGJjOTUwMzM5ODU2NjRjNTNkMGU1YS9wMDAxLnBuZw" }, { "docId": "019de076-b194-750c-a1e9-eae1d42bc6f5", "docSlug": "9fdf48e9810bc95033985664c53d0e5a", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 24 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "appendix_disclosure", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b194-750c-a1e9-eae1d42bc6f5/2", "deckHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5", "deckAnchorHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b194-750c-a1e9-eae1d42bc6f5", "docSlug": "9fdf48e9810bc95033985664c53d0e5a", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 24 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "executive_summary", "function": "summarize", "notes": "The slide uses a 2x3 grid layout to present key company pillars.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b194-750c-a1e9-eae1d42bc6f5/3", "deckHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5", "deckAnchorHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b194-750c-a1e9-eae1d42bc6f5", "docSlug": "9fdf48e9810bc95033985664c53d0e5a", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 24 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "business_model", "function": "present_solution", "notes": "The slide contrasts the company's decentralized approach against centralized CLIA lab competitors.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b194-750c-a1e9-eae1d42bc6f5/4", "deckHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5", "deckAnchorHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5#slide-4", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b194-750c-a1e9-eae1d42bc6f5", "docSlug": "9fdf48e9810bc95033985664c53d0e5a", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 24 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "transition", "function": "transition", "notes": "The slide uses a minimalist design with a halftone pattern and company branding.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b194-750c-a1e9-eae1d42bc6f5/5", "deckHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5", "deckAnchorHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5#slide-5", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b194-750c-a1e9-eae1d42bc6f5", "docSlug": "9fdf48e9810bc95033985664c53d0e5a", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 24 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "product_demo", "function": "present_solution", "notes": "Includes a process diagram for the test workflow and product imagery.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b194-750c-a1e9-eae1d42bc6f5/6", "deckHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5", "deckAnchorHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5#slide-6", "loopMatches": [], "arcBeatMatches": [ { "to": 6, "from": 6, "beatId": "cdc5e23b-2b8b-45a9-a33c-b13dc7321467", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Product", "beatSlug": "sequoia-pitch-product", "evidence": "Slides 5 and 6 present the flagship product ColoAlert", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b194-750c-a1e9-eae1d42bc6f5", "docSlug": "9fdf48e9810bc95033985664c53d0e5a", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 24 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "solution", "function": "present_solution", "notes": "The slide outlines the technical workflow from sample collection to diagnostic output.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b194-750c-a1e9-eae1d42bc6f5/7", "deckHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5", "deckAnchorHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5#slide-7", "loopMatches": [], "arcBeatMatches": [ { "to": 7, "from": 7, "beatId": "9d528a25-ffbf-44a3-8c43-b1f445f06646", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Slide 7 presents the solution using DNA biomarkers for early CRC detection", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b194-750c-a1e9-eae1d42bc6f5", "docSlug": "9fdf48e9810bc95033985664c53d0e5a", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 24 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a 3-column layout to categorize achievements by strategic pillar.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b194-750c-a1e9-eae1d42bc6f5/8", "deckHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5", "deckAnchorHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5#slide-8", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b194-750c-a1e9-eae1d42bc6f5", "docSlug": "9fdf48e9810bc95033985664c53d0e5a", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 24 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "cover", "function": "front_matter", "notes": "The slide features a minimalist design with a corporate logo and a halftone dot pattern.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b194-750c-a1e9-eae1d42bc6f5/9", "deckHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5", "deckAnchorHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5#slide-9", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b194-750c-a1e9-eae1d42bc6f5", "docSlug": "9fdf48e9810bc95033985664c53d0e5a", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 24 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "problem_statement", "function": "frame_problem", "notes": "The slide uses a visual timeline/process flow to show disease progression.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b194-750c-a1e9-eae1d42bc6f5/10", "deckHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5", "deckAnchorHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5#slide-10", "loopMatches": [ { "to": 11, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "2e5f5f19-b542-4f7b-b668-a00aa4389c6f", "evidence": "Slides 10 and 11 present the problem and the benefits of including AAs detection in screening tests", "position": 0, "objective": "The cost of inaction in CRC screening", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 10, "from": 10, "beatId": "47f508e5-a5e9-4c33-b61b-01e4f944bee1", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "Slide 10 presents the problem statement on early identification of colorectal cancer", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b194-750c-a1e9-eae1d42bc6f5", "docSlug": "9fdf48e9810bc95033985664c53d0e5a", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 24 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "why_now", "function": "argue_timing", "notes": "The slide uses data from a 2022 JNCI study to justify the clinical importance of AA detection sensitivity.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b194-750c-a1e9-eae1d42bc6f5/11", "deckHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5", "deckAnchorHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5#slide-11", "loopMatches": [ { "to": 11, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "2e5f5f19-b542-4f7b-b668-a00aa4389c6f", "evidence": "Slides 10 and 11 present the problem and the benefits of including AAs detection in screening tests", "position": 0, "objective": "The cost of inaction in CRC screening", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 11, "from": 11, "name": "Why Now", "slug": "15-why-now", "bestFor": "Sales pitches, fundraising, requesting immediate budget approval", "matchId": "7cf3075b-054e-4d1a-93de-425d0a585948", "evidence": "Slide 11 presents the why now section", "position": 1, "objective": "Why now is the time for Mainz Biomed's solution", "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity", "confidence": 0.6, "description": "Create temporal urgency by proving that the window of opportunity is opening or closing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b194-750c-a1e9-eae1d42bc6f5", "docSlug": "9fdf48e9810bc95033985664c53d0e5a", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 24 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "product_demo", "function": "present_solution", "notes": "The slide highlights the integration of mRNA and DNA biomarkers into a proprietary algorithm for colorectal cancer (CRC) and advanced adenoma (AA) detection.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b194-750c-a1e9-eae1d42bc6f5/12", "deckHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5", "deckAnchorHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5#slide-12", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b194-750c-a1e9-eae1d42bc6f5", "docSlug": "9fdf48e9810bc95033985664c53d0e5a", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 24 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "timeline", "function": "plan_implementation", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b194-750c-a1e9-eae1d42bc6f5/13", "deckHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5", "deckAnchorHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5#slide-13", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b194-750c-a1e9-eae1d42bc6f5", "docSlug": "9fdf48e9810bc95033985664c53d0e5a", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 24 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "traction", "function": "show_traction", "notes": "The table compares two distinct clinical trials (ColoFuture and eAArly DETECT) across key performance metrics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b194-750c-a1e9-eae1d42bc6f5/14", "deckHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5", "deckAnchorHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5#slide-14", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b194-750c-a1e9-eae1d42bc6f5", "docSlug": "9fdf48e9810bc95033985664c53d0e5a", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 24 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The slide uses two scatter plots to benchmark the company against competitors like Guardant Health, CellMax Life, and Cologuard.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b194-750c-a1e9-eae1d42bc6f5/15", "deckHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5", "deckAnchorHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5#slide-15", "loopMatches": [], "arcBeatMatches": [ { "to": 15, "from": 15, "beatId": "0afa9093-44aa-47ec-a847-b90e9f562f69", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "Slide 15 presents competitive analysis and market size information", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b194-750c-a1e9-eae1d42bc6f5", "docSlug": "9fdf48e9810bc95033985664c53d0e5a", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 24 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b194-750c-a1e9-eae1d42bc6f5/16", "deckHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5", "deckAnchorHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5#slide-16", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b194-750c-a1e9-eae1d42bc6f5", "docSlug": "9fdf48e9810bc95033985664c53d0e5a", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 24 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a horizontal timeline format to map product milestones against calendar years.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b194-750c-a1e9-eae1d42bc6f5/17", "deckHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5", "deckAnchorHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5#slide-17", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b194-750c-a1e9-eae1d42bc6f5", "docSlug": "9fdf48e9810bc95033985664c53d0e5a", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 24 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "roadmap", "function": "plan_implementation", "notes": "Slide 18 of a pitch deck.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b194-750c-a1e9-eae1d42bc6f5/18", "deckHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5", "deckAnchorHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5#slide-18", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b194-750c-a1e9-eae1d42bc6f5", "docSlug": "9fdf48e9810bc95033985664c53d0e5a", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 24 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "team_bio", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b194-750c-a1e9-eae1d42bc6f5/19", "deckHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5", "deckAnchorHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5#slide-19", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 19, "beatId": "094ed220-c5e2-4649-947d-ee0f4fc460b9", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Team", "beatSlug": "sequoia-pitch-team", "evidence": "Slides 19 and 20 present the leadership team and industry advisors", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b194-750c-a1e9-eae1d42bc6f5", "docSlug": "9fdf48e9810bc95033985664c53d0e5a", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 24 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "team_bio", "function": "other", "notes": "The slide uses a grid layout to present 10 advisors, each with a headshot, name, role, and company logo.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b194-750c-a1e9-eae1d42bc6f5/20", "deckHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5", "deckAnchorHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5#slide-20", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 19, "beatId": "094ed220-c5e2-4649-947d-ee0f4fc460b9", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Team", "beatSlug": "sequoia-pitch-team", "evidence": "Slides 19 and 20 present the leadership team and industry advisors", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b194-750c-a1e9-eae1d42bc6f5", "docSlug": "9fdf48e9810bc95033985664c53d0e5a", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 24 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a DNA helix as a creative timeline background, reflecting the company's focus on molecular diagnostics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b194-750c-a1e9-eae1d42bc6f5/21", "deckHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5", "deckAnchorHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5#slide-21", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b194-750c-a1e9-eae1d42bc6f5", "docSlug": "9fdf48e9810bc95033985664c53d0e5a", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 24 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes income statement metrics, balance sheet data, and equity structure.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b194-750c-a1e9-eae1d42bc6f5/22", "deckHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5", "deckAnchorHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5#slide-22", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b194-750c-a1e9-eae1d42bc6f5", "docSlug": "9fdf48e9810bc95033985664c53d0e5a", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 24 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "executive_summary", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b194-750c-a1e9-eae1d42bc6f5/23", "deckHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5", "deckAnchorHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5#slide-23", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b194-750c-a1e9-eae1d42bc6f5", "docSlug": "9fdf48e9810bc95033985664c53d0e5a", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 24 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "closing_ask", "function": "state_next_steps", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b194-750c-a1e9-eae1d42bc6f5/24", "deckHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5", "deckAnchorHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5#slide-24", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b279-75da-94b2-8ad8944b7652", "docSlug": "3080df08d7a75d95f523d4df26f037ae", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/2p7UWbazKfrxoGoTDmfFZmCCYfm5OF0QEHlDN-BT8jQ/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zMDgwZGYwOGQ3YTc1ZDk1ZjUyM2Q0ZGYyNmYwMzdhZS9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/1", "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652", "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/0gjAf-Js4rjYwSxV2OT9HXlpu-4kSVrpo8t4PM-wMGI/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zMDgwZGYwOGQ3YTc1ZDk1ZjUyM2Q0ZGYyNmYwMzdhZS9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/Om9Byg8-2okK-mMbsKirHvWpFADZHJ41h8pGbdDaNQs/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zMDgwZGYwOGQ3YTc1ZDk1ZjUyM2Q0ZGYyNmYwMzdhZS9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/dK4vbJ3D0z4CX8F5pdSxjEhmfytxRS1e0-Eh4hZ1Jko/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zMDgwZGYwOGQ3YTc1ZDk1ZjUyM2Q0ZGYyNmYwMzdhZS9wMDAxLnBuZw" }, { "docId": "019de076-b279-75da-94b2-8ad8944b7652", "docSlug": "3080df08d7a75d95f523d4df26f037ae", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/2", "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652", "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b279-75da-94b2-8ad8944b7652", "docSlug": "3080df08d7a75d95f523d4df26f037ae", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "thesis_headline", "function": "present_solution", "notes": "The slide uses a two-column layout to contrast a specific lead asset (MAT2203) with broader pipeline opportunities.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/3", "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652", "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b279-75da-94b2-8ad8944b7652", "docSlug": "3080df08d7a75d95f523d4df26f037ae", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a combination of molecular diagrams and bulleted benefits to explain the LNC technology.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/4", "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652", "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-4", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b279-75da-94b2-8ad8944b7652", "docSlug": "3080df08d7a75d95f523d4df26f037ae", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a two-part framework: Targeting (left) and Delivery (right).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/5", "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652", "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-5", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b279-75da-94b2-8ad8944b7652", "docSlug": "3080df08d7a75d95f523d4df26f037ae", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/6", "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652", "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-6", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b279-75da-94b2-8ad8944b7652", "docSlug": "3080df08d7a75d95f523d4df26f037ae", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "why_now", "function": "argue_timing", "notes": "Uses authority-citation framework to build urgency by aggregating external validation from reputable news and scientific sources.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/7", "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652", "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-7", "loopMatches": [ { "to": 14, "from": 7, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "280995d8-784d-4cf6-887d-11df1485e9b8", "evidence": "The document emphasizes the growing threat of IFIs", "position": 0, "objective": "Highlight the consequences of not addressing IFIs", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 14, "from": 7, "beatId": "7aa25a8a-9932-4625-b5d8-1d7641445816", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem (Identify pain)", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "The document identifies the growing threat of IFIs and high unmet medical need in IA", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b279-75da-94b2-8ad8944b7652", "docSlug": "3080df08d7a75d95f523d4df26f037ae", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "solution", "function": "present_solution", "notes": "Uses a before-after-bridge style logic to frame the solution.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/8", "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652", "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-8", "loopMatches": [ { "to": 14, "from": 7, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "280995d8-784d-4cf6-887d-11df1485e9b8", "evidence": "The document emphasizes the growing threat of IFIs", "position": 0, "objective": "Highlight the consequences of not addressing IFIs", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 14, "from": 7, "beatId": "7aa25a8a-9932-4625-b5d8-1d7641445816", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem (Identify pain)", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "The document identifies the growing threat of IFIs and high unmet medical need in IA", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" }, { "to": 17, "from": 8, "beatId": "eafaf135-71d7-4ccf-a416-5600c022e3da", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents MAT2203 as a solution and provides supporting evidence", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b279-75da-94b2-8ad8944b7652", "docSlug": "3080df08d7a75d95f523d4df26f037ae", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a process flow diagram to map clinical outcomes to specific trial metrics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/9", "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652", "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-9", "loopMatches": [ { "to": 14, "from": 7, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "280995d8-784d-4cf6-887d-11df1485e9b8", "evidence": "The document emphasizes the growing threat of IFIs", "position": 0, "objective": "Highlight the consequences of not addressing IFIs", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 14, "from": 7, "beatId": "7aa25a8a-9932-4625-b5d8-1d7641445816", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem (Identify pain)", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "The document identifies the growing threat of IFIs and high unmet medical need in IA", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" }, { "to": 17, "from": 8, "beatId": "eafaf135-71d7-4ccf-a416-5600c022e3da", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents MAT2203 as a solution and provides supporting evidence", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b279-75da-94b2-8ad8944b7652", "docSlug": "3080df08d7a75d95f523d4df26f037ae", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "traction", "function": "show_traction", "notes": "This is a citation slide showcasing scientific validation of the company's technology.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/10", "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652", "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-10", "loopMatches": [ { "to": 14, "from": 7, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "280995d8-784d-4cf6-887d-11df1485e9b8", "evidence": "The document emphasizes the growing threat of IFIs", "position": 0, "objective": "Highlight the consequences of not addressing IFIs", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 14, "from": 7, "beatId": "7aa25a8a-9932-4625-b5d8-1d7641445816", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem (Identify pain)", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "The document identifies the growing threat of IFIs and high unmet medical need in IA", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" }, { "to": 17, "from": 8, "beatId": "eafaf135-71d7-4ccf-a416-5600c022e3da", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents MAT2203 as a solution and provides supporting evidence", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b279-75da-94b2-8ad8944b7652", "docSlug": "3080df08d7a75d95f523d4df26f037ae", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a human silhouette as a central diagram to map specific fungal pathogens and resulting conditions to anatomical locations.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/11", "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652", "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-11", "loopMatches": [ { "to": 14, "from": 7, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "280995d8-784d-4cf6-887d-11df1485e9b8", "evidence": "The document emphasizes the growing threat of IFIs", "position": 0, "objective": "Highlight the consequences of not addressing IFIs", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 14, "from": 7, "beatId": "7aa25a8a-9932-4625-b5d8-1d7641445816", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem (Identify pain)", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "The document identifies the growing threat of IFIs and high unmet medical need in IA", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" }, { "to": 17, "from": 8, "beatId": "eafaf135-71d7-4ccf-a416-5600c022e3da", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents MAT2203 as a solution and provides supporting evidence", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b279-75da-94b2-8ad8944b7652", "docSlug": "3080df08d7a75d95f523d4df26f037ae", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "traction", "function": "show_traction", "notes": "Focuses on clinical success in a compassionate use setting.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/12", "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652", "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-12", "loopMatches": [ { "to": 14, "from": 7, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "280995d8-784d-4cf6-887d-11df1485e9b8", "evidence": "The document emphasizes the growing threat of IFIs", "position": 0, "objective": "Highlight the consequences of not addressing IFIs", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 14, "from": 7, "beatId": "7aa25a8a-9932-4625-b5d8-1d7641445816", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem (Identify pain)", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "The document identifies the growing threat of IFIs and high unmet medical need in IA", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" }, { "to": 17, "from": 8, "beatId": "eafaf135-71d7-4ccf-a416-5600c022e3da", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents MAT2203 as a solution and provides supporting evidence", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b279-75da-94b2-8ad8944b7652", "docSlug": "3080df08d7a75d95f523d4df26f037ae", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "other", "function": "illustrate_case", "notes": "The slide uses a timeline-based case study format to demonstrate clinical efficacy and safety.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/13", "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652", "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-13", "loopMatches": [ { "to": 14, "from": 7, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "280995d8-784d-4cf6-887d-11df1485e9b8", "evidence": "The document emphasizes the growing threat of IFIs", "position": 0, "objective": "Highlight the consequences of not addressing IFIs", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 14, "from": 7, "beatId": "7aa25a8a-9932-4625-b5d8-1d7641445816", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem (Identify pain)", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "The document identifies the growing threat of IFIs and high unmet medical need in IA", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" }, { "to": 17, "from": 8, "beatId": "eafaf135-71d7-4ccf-a416-5600c022e3da", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents MAT2203 as a solution and provides supporting evidence", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b279-75da-94b2-8ad8944b7652", "docSlug": "3080df08d7a75d95f523d4df26f037ae", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "problem_statement", "function": "frame_problem", "notes": "The slide highlights both the clinical urgency (toxicity, resistance) and the commercial potential (orphan disease status).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/14", "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652", "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-14", "loopMatches": [ { "to": 14, "from": 7, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "280995d8-784d-4cf6-887d-11df1485e9b8", "evidence": "The document emphasizes the growing threat of IFIs", "position": 0, "objective": "Highlight the consequences of not addressing IFIs", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 14, "from": 7, "beatId": "7aa25a8a-9932-4625-b5d8-1d7641445816", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem (Identify pain)", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "The document identifies the growing threat of IFIs and high unmet medical need in IA", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" }, { "to": 14, "from": 14, "beatId": "4c746dd8-1e95-4d84-97e7-5921f00a9ef1", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate (Make it worse)", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "The document highlights the limitations of current treatments", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" }, { "to": 17, "from": 8, "beatId": "eafaf135-71d7-4ccf-a416-5600c022e3da", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents MAT2203 as a solution and provides supporting evidence", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b279-75da-94b2-8ad8944b7652", "docSlug": "3080df08d7a75d95f523d4df26f037ae", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "roadmap", "function": "plan_implementation", "notes": "Focuses on clinical trial strategy and regulatory milestones.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/15", "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652", "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-15", "loopMatches": [ { "to": 17, "from": 15, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "00b1ada5-9ed0-47ca-b8a0-eb84773cc71e", "evidence": "The document outlines the value proposition of MAT2203", "position": 1, "objective": "Present MAT2203 as a solution with high potential", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 17, "from": 8, "beatId": "eafaf135-71d7-4ccf-a416-5600c022e3da", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents MAT2203 as a solution and provides supporting evidence", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b279-75da-94b2-8ad8944b7652", "docSlug": "3080df08d7a75d95f523d4df26f037ae", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "appendix_methodology", "function": "plan_implementation", "notes": "The slide outlines the randomization, treatment arms, timeline, patient population criteria, and primary/secondary endpoints.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/16", "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652", "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-16", "loopMatches": [ { "to": 17, "from": 15, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "00b1ada5-9ed0-47ca-b8a0-eb84773cc71e", "evidence": "The document outlines the value proposition of MAT2203", "position": 1, "objective": "Present MAT2203 as a solution with high potential", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 17, "from": 8, "beatId": "eafaf135-71d7-4ccf-a416-5600c022e3da", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents MAT2203 as a solution and provides supporting evidence", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b279-75da-94b2-8ad8944b7652", "docSlug": "3080df08d7a75d95f523d4df26f037ae", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "solution", "function": "present_solution", "notes": "Uses a combination of an additive equation for the value prop and a chevron-based timeline for the life cycle management.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/17", "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652", "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-17", "loopMatches": [ { "to": 17, "from": 15, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "00b1ada5-9ed0-47ca-b8a0-eb84773cc71e", "evidence": "The document outlines the value proposition of MAT2203", "position": 1, "objective": "Present MAT2203 as a solution with high potential", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 17, "from": 8, "beatId": "eafaf135-71d7-4ccf-a416-5600c022e3da", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents MAT2203 as a solution and provides supporting evidence", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b279-75da-94b2-8ad8944b7652", "docSlug": "3080df08d7a75d95f523d4df26f037ae", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/18", "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652", "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-18", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b279-75da-94b2-8ad8944b7652", "docSlug": "3080df08d7a75d95f523d4df26f037ae", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a matrix-like structure to map disease areas (Infection, Inflammation, Oncology) to specific animal models and clinical indications.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/19", "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652", "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-19", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b279-75da-94b2-8ad8944b7652", "docSlug": "3080df08d7a75d95f523d4df26f037ae", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "roadmap", "function": "plan_implementation", "notes": "Uses a chevron-based process flow to represent maturity stages.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/20", "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652", "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-20", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b279-75da-94b2-8ad8944b7652", "docSlug": "3080df08d7a75d95f523d4df26f037ae", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "traction", "function": "show_traction", "notes": "The chart shows dose-response curves where LNC formulations consistently outperform Taxol.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/21", "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652", "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-21", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b279-75da-94b2-8ad8944b7652", "docSlug": "3080df08d7a75d95f523d4df26f037ae", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a timeline diagram to explain the experimental design and a line chart to show tumor volume reduction over time.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/22", "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652", "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-22", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b279-75da-94b2-8ad8944b7652", "docSlug": "3080df08d7a75d95f523d4df26f037ae", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "traction", "function": "show_traction", "notes": "The study is an ex-vivo human whole blood study using 80 ug/mL LNC and 512 ng/mL Cy5-labeled siRNA cargo.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/23", "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652", "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-23", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b279-75da-94b2-8ad8944b7652", "docSlug": "3080df08d7a75d95f523d4df26f037ae", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide compares LNC formulations against IMQ-only and IL-17A antibody controls.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/24", "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652", "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-24", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b279-75da-94b2-8ad8944b7652", "docSlug": "3080df08d7a75d95f523d4df26f037ae", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes study design details (n=55, female C57BL/6 mice) and statistical significance markers for treatment groups.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/25", "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652", "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-25", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }